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Military Breachers and Range Staff (MBRS) are subjected to repeated sub-concussive
blasts, and they often report symptoms that are consistent with a mild traumatic brain
injury (mTBI). Biomarkers of blast injury would potentially aid blast injury diagnosis,
surveillance and avoidance. Our objective was to identify plasma metabolite biomarkers
in military personnel that were exposed to repeated low-level or sub-concussive blast
overpressure. A total of 37 military members were enrolled (18 MBRS and 19 controls),
with MBRS having participated in 8–20 breaching courses per year, with a maximum
exposure of 6 blasts per day. The two cohorts were similar except that the number
of blast exposures were significantly higher in the MBRS, and the MBRS cohort
suffered significantly more post-concussive symptoms and poorer health on assessment.
Metabolomics profiling demonstrated significant differences between groups with 74%
MBRS classification accuracy (CA). Feature reduction identified 6 metabolites that
resulted in a MBRS CA of 98%, and included acetic acid (23.7%), formate (22.6%),
creatine (14.8%), acetone (14.2%), methanol (12,7%), and glutamic acid (12.0%). All 6
metabolites were examined with individual receiver operating characteristic (ROC) curve
analyses and demonstrated areas-under-the-curve (AUCs) of 0.82–0.91 (P ≤ 0.001)
for MBRS status. Several parsimonious combinations of three metabolites increased
accuracy of ROC curve analyses to AUCs of 1.00 (P < 0.001), while a combination of
volatile organic compounds (VOCs; acetic acid, acetone and methanol) yielded an AUC
of 0.98 (P < 0.001). Candidate biomarkers for chronic blast exposure were identified,
and if validated in a larger cohort, may aid surveillance and care of military personnel.
Future point-of-care screening could be developed that measures VOCs from breath,
with definitive diagnoses confirmed with plasma metabolomics profiling.
Keywords: military, blast, mild traumatic brain injury, metabolites, biomarkers
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INTRODUCTION

recruitment poster that was circulated among the Canadian
Forces School of Military Engineering (CFSME) staff (MBRS)
and at Denison Armory (for non-MBRS or controls)
(7). Blast quantification was not attempted; however, the
instructors and range staff potentially contribute to eighttwenty breaching courses per year with one-two days of
breaching on the range. The instructors and range staff form
a “cell” that administer the courses together for a period
of one-three years; while they may be exposed to more
than six blasts per day, the magnitude and number of blast
events varies.
All data were collected in a single session for each
participant. CFSME MBRS were tested at Canadian Forces Base
Gagetown. Sex- and age-matched CAF controls were tested at
DRDC TRC (Toronto Research Center). The measures included
neuropsychological and neurocognitive tasks, as well as blood
procurement for biomarker studies. Specifically, participants
completed a demographic and service history survey, a
Background Health Questionnaire, the RAND SF-36 Health
Survey, the Short Musculoskeletal Function Questionnaire
(SMFA), a modified version of the Rivermead Post-Concussion
Symptoms Questionnaire and a Post-Traumatic Checklist (PCL5) (please see Supplementary Table 1 for additional information
on each survey) (22–26).
All blood samples were collected via strict standard operating
procedures. The participants had not been exposed to blast for
a minimum of 48 h and were asked to refrain from strenuous
physical activity for at least 24 h prior to testing. Peripheral blood
was collected by venipuncture from participants at rest and in a
fasting state by a trained technologist using standard phlebotomy
techniques. Venous blood samples were drawn into 10-mL
EDTA tubes, immediately centrifuged at 1,600 × g for 15 min
at 4◦ C, separated into plasma aliquots, and stored at −80◦ C
until analysis. All samples were processed in the same manner
at the same time of day by the same technologist(s). A targeted
quantitative approach was applied to analyze plasma samples
using both a 1 H NMR and a combination of direct injection
tandem MS (DI-MS/MS) and liquid chromatography tandem
MS (LC-MS/MS) using the AbsoluteIDQ p180 kit (Biocrates
Life Sciences, AG, Innsbruck, Austria), as previously described
(27, 28). In the event of metabolite repeats measured with
both techniques, the 1 H NMR metabolite measurements were
deleted from the combined metabolite database and only DI-MS
data analyzed.
For feature selection and classification accuracy, the raw
data for each subject were ingested within each feature, across
subjects. A random forest classifier was trained on the variables
to predict MBRS status (“scikit-learn” module for Python 3.8.5
Open Source). A random forest is a set of decision trees, and
consequently, we were able to interrogate this collection of trees
to identify the features that had the highest predictive value.
Feature selection was not performed in preprocessing. During
training, the random forest classifier performed an implicit
feature selection; the top features were those that appear highest
ranked in the most trees. To reduce overfitting, the number of
trees and maximum depth of each tree was limited (29); thus,
MBRS status was determined using a 3-fold cross validation with
a random forest of ten trees and maximum depth of three. To

Blast exposure is common in military service (1, 2). A blast wave
is generated by an explosion, resulting in a sudden increase in
air pressure that is followed by negative pressure, or suction of
the blast wave (3). The injury magnitude of a blast wave depends
on multiple variables, including the peak of the initial positivepressure wave, the duration of the overpressure, the medium
of the explosion, the distance from the incident blast wave,
and the degree of focusing due to a confined area or walls (4).
Military breachers and range staff (MBRS) are routinely exposed
to repetitive low-level blasts of 2–3 pounds per square inch (psi;
or 14–21 kPa) during training and deployment (5–8). Larger blast
exposure in the range of 60–80 psi (414–522 kPa) are considered
lethal (9).
While the entire body is susceptible to blast injury, the
brain seems particularly vulnerable (4). A blast wave not only
reflects off the skull, but the generated energy of the shock
wave is also absorbed by the brain tissues (3). The kinetic
injury from thoracoabdominal compression can also result in
transmitted forces to the brain via blood vessels. Regardless
of the mechanism, post-blast neurocognitive deficits have been
demonstrated in animal models and humans (10, 11). Repetitive
low-level blasts, while unlikely to cause mechanical trauma via
acceleration and/or rotation of the head, nevertheless result in
neuropsychological and neurocognitive deficits and generally
decreased physical and mental health (7, 12, 13).
Animal models of blast injury have suggested metabolic
impairments that include altered glucose metabolism, associated
with a shift from aerobic to anaerobic metabolic pathways.
Indeed, increased lactate/pyruvate ratio has been reported
(14), followed by decreased energy reserve (14, 15), oxidative
stress (16) and inflammation (16–20). The alterations in energy
metabolism suggest that blast investigations would benefit
from metabolomic profiling, or the measurement of a subject’s
small metabolite profile, including amino acids, acylcarnitines,
glycerophospholipids, sphingolipids, sugars and volatile organic
compounds (VOC) (21). Two complementary analytical
methods for metabolomics are proton nuclear magnetic
resonance (1 H NMR) spectroscopy and mass spectrometry
(MS), yielding measurement accuracies in the µM and pM
ranges, respectively.
As the consequences of long-term exposure to repetitive lowlevel blasts is largely unknown, as are the injury thresholds, or
when blast exposure initiates poorer health and compromised
well-being, identification of accurate blast biomarkers and assays
is critical to understanding blast exposure pathophysiology.
Thus, the aims of this study were (1) to profile two Canadian
Armed Forces (CAF) military cohorts (MBRS and non-MBRS)
with metabolomics, (2) to identify novel metabolite biomarkers
of MBRS with machine learning; and (3) to correlate biomarkers
with blast injury symptoms.

METHODS
The study protocol was approved by the Human Research
Ethics Committee of Defense Research and Development
Canada. Potential participants were recruited via an electronic
Frontiers in Neurology | www.frontiersin.org
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remain conservative and to further limit the risk of overfitting,
no hyperparameters were tuned or optimized by design and
intent. For feature selection, the samples were split into statusstratified training (70%) and validation sets (30%). A Boruta
feature selection method, based on random forest classifiers, was
then used to develop a reduced model using the training dataset
(30). The reduced metabolite dataset was then visualized with a
non-linear dimensionality reduction on the full data matrix using
the t-distributed stochastic nearest neighbor embedding (t-SNE)
algorithm (31). t-SNE assumes that the “optimal” representation
of the data lies on a manifold with complex geometry, but with
low dimension, embedded in the full-dimensional space of the
raw data.
Medians (IQRs) and frequency (%) were used to report
continuous and categorical variables, respectively. Continuous
variables were compared using Mann-Whitney U tests, and
categorical variables were compared using chi-square tests (or
Fisher’s exact chi-square, as appropriate). Receiver operating
characteristic (ROC) curves were estimated for individual
metabolites and continuous outcomes in terms of predicting
MBRS status, with area-under-the-curve (AUC) >0.7 considered
acceptable. The coordinates of the curves for individual
metabolites were analyzed using Youden’s index to identify cutoff values in µM based on the highest sensitivity and specificity
for predicting MBRS status. Metabolite combinations were
calculated through logistic regression models with MBRS status
as the outcome and the representative metabolites as the included
predictors; the predicted values from the regression models were
then saved for use in ROC curve analyses. All analyses were
conducted using SPSS version 27 (IBM Corp., Armonk, NY,
USA), and p-values < 0.05 were considered significant. Heat
maps depicting Pearson correlation values between metabolites
and outcomes were created in R (http://www.r-project.org) using
the ggplot2 version 3.3.3 package (32).

TABLE 1 | Military personnel demographics, service history and
injuries/exposures.
Variable

MBRS
(n = 18)

32 (27, 36)

32 (26, 38)

0.976

17 (90)

16 (89)

>0.994

Height (cm), med (IQR)

179 (173, 188)

179 (177, 183)

0.867

Weight (lbs), med (IQR)

188 (170, 200)

180 (168, 215)

0.855

Age (yrs), med (IQR)
Male sex, n (%)

Body mass index

25.1 (24.4, 28.8) 26.6 (23.8, 30.1)

Education, n (%)

P-value

0.704
0.633

High school

4 (21)

College

4 (21)

6 (33)

Undergraduate university

10 (53)

5 (28)

1 (5)

1 (6)

16 (84)

11 (61)

French

0 (0)

7 (39)

Other

3 (16)

0 (0)

Forces

8 (42)

9 (50)

Reserves

11 (58)

10 (53)

13 (68)

5 (28)

Senior NCM

0 (0)

11 (61)

Junior officer

6 (32)

2 (11)

5 (1, 11)

11 (9, 14)

Allergies, n (%)

6 (32)

3 (17)

0.447

Medications, n (%)

5 (26)

5 (29)

>0.994

Coffee/caffeine drinks/day, med
(IQR)

1 (1, 2)

2 (1.4, 3)

0.054

Alcoholic drinks/week, med (IQR)

2 (1, 5)

2.8 (1, 8.5)

0.384

Smoke, n (%)

2 (11)

3 (17)

0.660

Use drugs in last 6 mo, n (%)

0 (0)

1 (6)

0.472

Current cold/infection, n (%)

0 (0)

3 (17)

0.105

Exercise regularly, n (%)

18 (95)

15 (88)

0.593

Specific diet, n (%)

3 (16)

2 (11)

>0.994

Combat deployment

0 (0)

10 (63)a

<0.001*

Concussion

5 (26)

8 (47)

0.196

Head impact

11 (58)

9 (50)

0.630

Motor vehicle collision

9 (47)

14 (78)

0.057

Fall as a child

6 (32)

8 (44)

0.420

Physical fight

15 (79)

12 (67)

0.476

Blast exposure

2 (11)

18 (100)

<0.001*

Years breaching

0 (0.0)

6.5 (3.8, 10.0)

<0.001*

Years explosives

0 (0.0)

10.0 (6.8, 12.0)

<0.001*

Graduate university

6 (33)

First language, n (%)
English

0.001*

Military status, n (%)

0.630

Rank, n (%)
Junior NCM

Years of service, med (IQR)

RESULTS

<0.001*

0.005*

Injuries and exposures, n (%)

We prospectively included nineteen MBRS and nineteen ageand sex-matched non-MBRS (Table 1); the final MBRS cohort
number was eighteen as there was insufficient plasma from one
service member for analyses. Nonetheless, the two cohorts were
well-balanced for age, sex, education, military status, lifestyle and
injuries. The MBRS cohort was more likely to be francophone,
senior in rank, had a longer duration of service and combat
deployed. As expected, MBRS were exposed to a significantly
greater number of blasts.
The reported symptoms and health assessment data are
listed in Table 2. The MBRS cohort reported an increased
number of symptoms, with reduced general physical and mental
health. Energy was lower for the MBRS cohort, and functional
and emotional health suffered. The Rivermead Post-Concussion
Symptoms were worse for MBRSs, including both early and late
symptoms, as well as somatic, cognitive and emotional health.
Finally, perceived stress was significantly worse for MBRSs.
Metabolomic profiling of cohorts was accomplished with both
1 H NMR and DI-MS, with a total of one hundred and seventy

Frontiers in Neurology | www.frontiersin.org

Non-MBRS
(n = 19)

MBRS, military breachers/range staff. Continuous variables are presented as median
(IQR), and categorical variables are presented as n (%). a Data unavailable for 2 MBRS
members. *p < 0.05. Bold indicate statistical significance.

plasma metabolites measured. Cohort classification accuracy was
74% when the entire metabolome was ingested. Feature selection
narrowed the leading metabolites down to six, providing a
classification accuracy of 98% (Figure 1A). The six metabolites
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included acetic acid, formate, creatine, acetone, methanol and
glutamic acid, and all six were significantly lower in the MBRS
cohort (P ≤ 0.001; Table 3). A tSNE plot demonstrated near
perfect separation of cohorts based on the leading six metabolites
(Figure 1B). The decreased levels of acetic acid, creatine and
methanol correlated with increased symptom scores reported
on the Rivermead Post-Concussion Symptoms Questionnaire
(Figure 1C). ROC curve analyses of the 6 individual metabolites
for determining MBRS status demonstrated AUCs of 0.82–0.91
(P ≤ 0.001; Table 4). The cut-off values for each metabolite
were determined. Scatter plots with metabolite cut-off values are
shown for Rivermead early (RPQ3) and late (RPQ13) symptoms,
as well as RAND Energy (Supplementary Figures 1–3). We then
identified three parsimonious combinations of three metabolites
that perfectly predicted MBRS status with AUCs = 1.00 (P <
0.001; Table 4). One metabolite combination that consisted of
only VOCs, including acetic acid, acetone and methanol, yielded
an AUC of 0.98 (P < 0.001). The RAND energy level and
the Rivermead Post-Concussion Symptom Questionnaire scores
predicted both MBRS status and the parsimonious metabolite
combinations, yielding AUCs of 0.69–0.79 (Figure 1D; the
RAND Energy level not shown, AUC=0.73 [95% CI 0.56–0.90]).

TABLE 2 | Military personnel reported symptoms and health assessment.
Variable

Non-MBRS
(n = 19)

MBRS
(n = 18)

P-value

Reported symptoms
Chronic disease, n (%)

2 (11)

1 (6)

>0.994

Headache

0 (0, 2)

2 (1, 2.3)

0.010*

Dizziness

0 (0, 1)

1.5 (0, 2)

0.043*

Vomiting

0 (0, 0)

0 (0, 0.3)

0.356

Noise sensitivity

0 (0, 0)

0 (0, 2)

0.099

Sleep disturbance

0 (0, 0)

0.5 (0, 2)

0.011*

Fatigue

0 (0, 0)

1.5 (0, 2)

0.002*

Irritable

0 (0, 0)

1 (0, 2.3)

0.013*

Depressed

0 (0, 0)

0 (0, 1)

0.003*

Frustrated

0 (0, 0)

0.5 (0, 3)

0.006*

Forgetful

0 (0, 0)

1 (0, 2)

<0.001*

Poor concentration

0 (0, 0)

1 (0, 2)

<0.001*

Taking long to think

0 (0, 0)

1 (0, 1.3)

0.003*

Blurred vision

0 (0, 0)

0 (0, 0.3)

0.137

Double vision

0 (0, 0)

0 (0, 0.3)

0.137

Light sensitivity

0 (0, 0)

0 (0, 1)

0.030*

Restlessness

0 (0, 0)

0 (0, 1)

0.007*

Impaired comprehension

0 (0, 0)

0 (0, 1)

0.015*

Impaired reasoning

0 (0, 0)

0 (0, 1)

0.061

Impaired logic

0 (0, 0)

0 (0, 0.3)

0.131

General physical health

5 (4, 5)

4 (3, 4)

0.002*

General mental health

5 (4, 5)

4 (3.8, 4)

0.037*

DISCUSSION
In this study, we performed metabolomics profiling of CAF
members, both MBRS and non-MBRS. Our data confirm
that MBRS suffer post-concussive symptoms associated with
mTBI and poorer health. Reduced metabolite parsimonious
combinations identified MBRS status with 100% accuracy, and
a combination of three VOCs with 98% accuracy. Our data
suggest that repetitive exposure to low-level blasts in military
personnel may be potentially identified by measuring as few as
three metabolites.
Low-level blasts refer to controlled blast exposures that
occur during standard training procedures and some military
operations experienced by military personnel (33). While MBRS
are frequently exposed to low-level blast overpressure, exposures
are also prevalent for any service member firing artillery,
mortars, grenades and/or shoulder-fired weapons. Given the
exposure frequency, it is not surprising that up to one quarter of
military service members experience post-concussive symptoms
(1, 2). Exposure to a 4 psi (28 kPa) blast is considered to be
minimally harmful; however, these thresholds were established
based on tympanic membrane rupture (5, 34) and neglect the
cumulative consequences of repetitive exposures to low-level
blast events. The military doctrine limits blast exposure to 3
psi (21 kPa); however, these values were often exceeded when
military personnel exposed to blasts wore pressure gauges (8, 34).
Metabolomics profiling of CAF members included use
of both 1 H NMR and DI-LC-MS/MS to yield quantitative
measurements of 170 metabolites. Feature selection identified
the leading 6 metabolites for determining MBRS status, with a
98% classification accuracy. Of the 6 leading metabolites, five
are related to energy metabolism (acetic acid, formate, creatine,
acetone and methanol), and one is an excitatory amino acid

RAND SF-36 Health Survey
Physical functioning

100 (95, 100)

98 (94, 100)

0.278

Physical limitations

100 (100, 100)

100 (94, 100)

0.866

Emotional limitations

100 (67, 100)

100 (92, 100)

0.346

65 (60, 80)

48 (35, 66)

0.017*

Energy
Emotional well-being

84 (68, 88)

78 (60, 88)

0.540

100 (75, 100)

100 (81, 100)

0.727

General health

80 (65, 95)

75 (63, 80)

0.285

Pain

90 (80, 100)

90 (79, 93)

0.187

Social functioning

Short musculoskeletal function assessment (SMFA)
Function

34.0 (34.0, 41.0) 40.0 (37.0, 47.0)

0.018*

Bother

12.0 (12.0, 17.0) 15.0 (12.8, 17.8)

0.092

Daily activities

10.0 (10.0, 10.0) 10.0 (10.0, 11.3)

Emotional status
Arm and hand
Mobility

7.0 (7.0, 13.0)

0.321

11.5 (9.0, 16.3)

0.011*

8 (8, 8)

8 (8, 8)

0.323

9.0 (9.0, 10.0)

9.0 (9.0, 12.3)

0.577

Rivermead post concussion symptom questionnaire
RPQ3

0 (0, 2.0)

2.5 (1.0, 6.0)

0.004*

RPQ13

0 (0, 3.0)

9.0 (0.8, 17.8)

0.001*

Somatic

0 (0, 0.2)

0.6 (0, 1.4)

0.006*

Cognitive

0 (0, 0)

0 (0, 1.5)

0.005*

Emotional

0 (0, 0)

0 (0, 1.3)

0.003*

0 (0, 9)

6 (0, 11)

0.106

Post-traumatic stress disorder
(PTSD)

MBRS, military breachers/range staff. Continuous variables are presented as median
(IQR), and categorical variables are presented as n (%). *p < 0.05. Bold indicate statistical
significance.
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FIGURE 1 | Metabolites identified with feature selection that determine military breacher/range staff (MBRS) status and their relationship with Rivermead
post-concussion variables. (A) A rank order of six leading plasma metabolites that classify MBRS vs. non-MBRS with 98% classification accuracy. All six metabolites
are significantly decreased in plasma from MBRS when compared to non-MBRS. Their relative % importance is shown. (B) A tSNE plot demonstrating that MBRS
and non-MBRS can be easily separated and identified based on plasma levels of the leading six metabolites. The axes are dimension-less. (C) A heat map
demonstrating the negative correlations between Rivermead post-concussion variables and plasma levels of the six leading metabolites. Brighter blue represents a
stronger negative correlation. Statistically significant negative correlations are indicated with white asterisks (*P < 0.05). (D) ROC curves illustrating that the Rivermead
post-concussion variables are predictive of MBRS status, as well as with the metabolite parsimonious combinations listed in Table 4 [RPQ13 (late symptoms) AUC =
0.79 [0.65–0.94], RPQ3 (early symptoms) AUC = 0.77 [95%CI 0.62–0.93], Somatic AUC = 0.75 [95%CI 0.58–0.91], Cognitive AUC = 0.71 [95%CI 0.53–0.88], and
Emotional AUC = 0.69 [95%CI 0.52–0.87].

classification accuracy. Three individual metabolites negatively
correlated with Rivermead Post-Concussion Symptoms
Questionnaire (acetic acid, creatine and methanol), while RAND
Energy and Rivermead early and late symptoms predicted
both MBRS status and the three metabolite parsimonious
combinations. Our metabolite biomarkers appear to offer a
promising complement or alternative to conventional protein
biomarker assays for identifying/characterizing blast exposures
(6, 35–37).
Acetic acid is absorbed from the gastrointestinal tract and
through the lung, or formed as a final product of enhanced
β-oxidation of fatty acids. Acetic acid is utilized as fuel in
extrahepatic tissues and may give rise to the production of
ketone bodies as intermediates. Consumption of acetic acid
improves glucose tolerance and insulin sensitivity (38, 39).
Supplementation with dietary acetic acid is well-tolerated, has no
adverse side effects, and may improve overall energy metabolism
(40). In the brain, acetic acid increases tricarboxylic acid cycle

TABLE 3 | Military personnel metabolite parameters.
Metabolite

Non-MBRS
(n = 19)

MBRS
(n = 18)

Direction

P-value

Acetic acid

36.6 (29.5, 43.5)

20.3 (14.5, 26.4)

↓

<0.001

Formate

58.1 (55.6, 303.8)

40.3 (38.4, 45.5)

↓

<0.001

Creatine

30.1 (25.7, 38.6)

20.7 (17.4, 26.3)

↓

<0.001

Acetone

15.8 (11.0, 17.6)

8.7 (7.4, 9.7)

↓

<0.001

Methanol

42.3 (28.6, 47.3)

24.8 (22.0, 31.5)

↓

<0.001

Glutamic acid

47.5 (37.1, 60.0)

28.2 (23.2, 37.1)

↓

0.001

MBRS, military breachers/range staff. Continuous variables are presented as median
(IQR). All biochemical values are in µM. *p < 0.05. Bold indicate statistical significance.

(glutamic acid). Classification accuracy for determining MBRS
status increased to 100% with three parsimonious combinations
of metabolites, while combining only VOCs resulted in a 98%
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as 2 h post-trauma (48). Gut dysbiosis may alter bacterial
fermentation-produced circulating methanol and formate levels
and thus impact 1C metabolism (including generation of
S-adenosylmethionine) (49). Dietary supplementation of 1C
sources, including formate, creatine, choline and betaine, may
help restore 1C metabolism and possibly ameliorate symptoms
of mTBI.
Acetone,
together
with
acetoacetate
and
betahydroxybutyrate, are the ketone by-products of fat metabolism
in the liver (50). Acetoacetate is formed from acetyl-CoA, and
then beta-oxidized to 3-beta-hydroxbutyrate. When required for
energy production, acetoacetate is converted back to acetyl-CoA
to be incorporated into the TCA cycle. Decarboxylation of excess
acetoacetate produces acetone, which cannot be used for energy
production directly and is either exhaled or excreted as waste.
However, acetone can also be converted into lactic acid within
the liver, which is then subsequently oxidized into pyruvic acid.
The latter can also produce acetyl-CoA to be incorporated into
the TCA cycle. The decreased plasma acetone levels measured
in MBRS members may reflect less acetoacetate decarboxylation
and/or greater acetone conversion to pyruvic acid, to compensate
energy deficits. In addition, elevating plasma ketones via dietary
manipulation (i.e., carbohydrate restriction) may improve
blast-induced symptoms (51). Indeed, ketones are actively
transported into brain via monocarboxylate transporters, and up
to two-thirds of brain metabolism can be fueled by ketones.
Glutamic acid is a non-essential amino acid that is a major
mediator of excitatory signals in the brain and is involved in most
aspects of normal brain function including cognition, memory
and learning (52). Measurements of glutamic acid in plasma
are generally thought to reflect brain levels, as there are no
glutamate degrading enzymes and regulation of glutamic acid
levels is controlled via cellular release and cellular uptake (53, 54).
High plasma glutamic acid levels are associated with acute/subacute TBI, as well as anxiety, autism, bipolar disorder, depression,
impulsivity and stroke. Low plasma glutamic acid levels are often
attributed to ammonia toxicity, and more recently, to Parkinson’s
disease (55). The low levels of glutamic acid found in plasma
from MBRS members may represent a relative exhaustion of
glutamate production after chronic low-level blast exposure,
and separates itself from the excessive glutamate release and
subsequent excitotoxicity suffered acutely after mechanical TBI.
It is also possible that a delayed disruption of excitatory glutamate
circuits may underlie the deficits in cognitive and motor function
reported by MRBS members. Finally, as glutamate clearance from
brain to blood occurs via gradient transport across the blood
brain barrier, blood glutamate scavenger mechanisms could be
upregulated, and may indirectly reflect ongoing brain injury or
healing mechanisms.
There is significant novelty and potential use of these data.
We report that a small number of metabolites can potentially
determine whom has been chronically exposed to low-level
blasts, and that the measured decreases in plasma metabolites
correlate with increased mTBI symptoms. Our data are supported
by the findings of our co-authors who demonstrated that putative
neurological biomarkers (S100beta, GFAP, UCH-L1, pNF-H, and
T-tau) were elevated in this chronic blast exposed military cohort

TABLE 4 | ROC curve summary predicting MBRS status.
Predictor(s)

AUC (SE)

95% CI

P-value Cut-off
value

Individual metabolites
Acetic acid

0.91 (0.05) 0.80–1.00 <0.001 < 28.26

Formate

0.89 (0.06) 0.77–1.00 <0.001 <53.16

Creatine

0.87 (0.06) 0.75–0.98 <0.001 <22.80

Acetone

0.90 (0.05) 0.80–1.00 <0.001 <10.77

Methanol

0.86 (0.06) 0.74–0.98 <0.001 <35.47

Glutamic acid

0.82 (0.08) 0.66 – 0.97

0.001

<36.90

Parsimonious combinations
Acetic acid, methanol, glutamic
acid

1.00 (0.00) 1.00–1.00 <0.001

-

Acetone, methanol, glutamic acid 1.00 (0.00) 1.00–1.00 <0.001

-

Creatine, methanol, glutamic acid 1.00 (0.00) 1.00–1.00 <0.001

-

Volatile organic compound
combination
Acetic acid, acetone, methanol

0.98 (0.00) 0.95–1.00 <0.001

-

MBRS, military breachers/range staff. Receiver operating characteristic (ROC) curves
were estimated for individual metabolites and continuous outcomes in terms of predicting
Breacher status, with area-under-the-curve (AUC) >0.7 considered acceptable.
Combinations were created using predicted values from a logistic regression with
Breacher status as the outcome and the metabolite combinations as the predictors. Cutoff values were calculated using Youden’s index, and are presented as µM. Bold indicate
statistical significance.

flux and neuronal excitability via glutamate neurotransmission
(41). As MBRS members had significant reductions in plasma
acetic acid, and its levels negatively correlated with mTBI
symptoms, it is possible that oral supplementation may aid the
low energy and neurocognitive symptoms identified by MBRS.
Creatine facilitates ATP homeostasis during energy turnover
and it acts as an antioxidant by attenuating reactive oxygen
species (42). In the brain, creatine is also important for
energy production via a brain-specific isoform of creatine
kinase. Creatine deficiencies result in mental and cognitive
derangements (43), which can be partially attenuated by creatine
supplementation (44). Creatine supplementation is suggested to
aid TBI outcome, and clinical trials on military personnel have
been encouraged (45). Indeed, creatine levels in MBRS members
negatively correlated with mTBI symptoms.
Formate is an intermediate in one-carbon (1C) metabolism
and is produced in a variety of metabolic reactions within cellular
compartments, including folate-dependent (e.g., via serine,
glycine, methionine, sarcosine and choline catabolism) and
folate-independent (e.g., catabolism of tryptophan, methionine
salvage, α-oxidation of branched chain fatty acids) reactions (46).
Formate can also be produced by anaerobic fermentation by the
gut microbiome (47). Fermentation of fruits and vegetables by
the microbiome can also produce methanol, which is metabolized
to formaldehyde and then formate by the liver. Animal studies
have demonstrated that spinal cord injuries cause a reduction
in intestinal motility and permeability, leading to alterations in
intestinal bacterial composition know as gut dysbiosis, whereas
TBI causes intestinal bacterial speciation changes as rapidly
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well-being of military personnel. Oral supplementation with
acetic acid, creatine and 1C sources, as well as carbohydrate
restriction (i.e., ketosis), may alleviate some blast-induced
symptoms related to brain energy metabolism, but support
for these interventions would require a rigorous randomized
controlled trial.

(Published Abstract; Rhind et al., Journal of Neurotrauma, 2018,
A99). Furthermore, a combination of VOCs can be accurately
measured with portable, hand-held breathalyzers, and may be
used as future point-of-care monitoring devices for service
members in both training and theater. A laboratory quantitative
test can be easily developed that would require analysis of a blood
sample with either 1 H NMR or quantitative mass spectrometry.
Indeed, the latter approach is currently under clinical testing
for concussion diagnostics, whereby the pattern of metabolite
change is unique and primarily lipidomic (56). As the metabolite
profile for repetitive blast exposure is unique, it is possible
that metabolite signatures will be useful for separating various
forms of trauma, including blast, mechanical, neurochemical
and psychological.
Our study was not without limitations. First, the number
of subjects investigated were limited and validation is required
in a larger cohort combined with brain-specific measurements.
Second, we cannot rule out that some metabolic changes may
be driven by chronic blast injury to peripheral organs. Third,
the metabolite patterns may not be generalizable to non-MBRS
or non-CFSME military members. Fourth, it is unclear if all
blasts, including repetitive high-caliber rifle fire and improvised
explosive device, would result in similar metabolite changes.
Fifth, the contribution of combat deployment to metabolite
changes in the MBRS cohort is unclear. Sixth, while the accurate
cut-off values for each plasma metabolite were established,
they require validation as injury warning thresholds. Despite
these caveats, our data suggest that MBRS can be monitored
for cumulative blast injury with both quantitative laboratory
approaches (1 H NMR and/or GC-MS/MS), and with future
point-of-care screening (e.g., breath VOCs).
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